Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samantha O Hasenleithner

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer Cell|December 13, 2022
How to detect cancer early using cell-free DNASamantha O Hasenleithner, Michael R Speicher
Molecular Cancer|March 21, 2022
A clinician's handbook for using ctDNA throughout the patient journeySamantha O Hasenleithner, Michael R Speicher
Computational and Structural Biotechnology Journal|December 11, 2024
LBFextract: Unveiling transcription factor dynamics from liquid biopsy dataIsaac Lazzeri, Benjamin Gernot Spiegl, Samantha O Hasenleithner, et al.
International Journal of Molecular Sciences|July 15, 2026
Off-Target-Based Tumor Fraction Estimation from Targeted Sequencing Shows Concordance with Orthogonal Methods Across Advanced Solid TumorsSamantha O Hasenleithner, Shilpa Rao, Jian Q Yu, et al.
Therapeutic Advances in Medical Oncology|March 15, 2021
Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trialJakob M Riedl, Samantha O Hasenleithner, Gudrun Pregartner, et al.
NPJ Precision Oncology|December 10, 2020
On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancerTina Moser, Julie Waldispuehl-Geigl, Jelena Belic, et al.
JCO Precision Oncology|January 7, 2022
Dynamic Changes of Circulating Tumor DNA Predict Clinical Outcome in Patients With Advanced Non-Small-Cell Lung Cancer Treated With Immune Checkpoint InhibitorsSabrina Weber, Paul van der Leest, Hylke C Donker, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer Cell|December 13, 2022
How to detect cancer early using cell-free DNASamantha O Hasenleithner, Michael R Speicher
Molecular Cancer|March 21, 2022
A clinician's handbook for using ctDNA throughout the patient journeySamantha O Hasenleithner, Michael R Speicher
Computational and Structural Biotechnology Journal|December 11, 2024
LBFextract: Unveiling transcription factor dynamics from liquid biopsy dataIsaac Lazzeri, Benjamin Gernot Spiegl, Samantha O Hasenleithner, et al.
International Journal of Molecular Sciences|July 15, 2026
Off-Target-Based Tumor Fraction Estimation from Targeted Sequencing Shows Concordance with Orthogonal Methods Across Advanced Solid TumorsSamantha O Hasenleithner, Shilpa Rao, Jian Q Yu, et al.
Therapeutic Advances in Medical Oncology|March 15, 2021
Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trialJakob M Riedl, Samantha O Hasenleithner, Gudrun Pregartner, et al.
NPJ Precision Oncology|December 10, 2020
On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancerTina Moser, Julie Waldispuehl-Geigl, Jelena Belic, et al.
JCO Precision Oncology|January 7, 2022
Dynamic Changes of Circulating Tumor DNA Predict Clinical Outcome in Patients With Advanced Non-Small-Cell Lung Cancer Treated With Immune Checkpoint InhibitorsSabrina Weber, Paul van der Leest, Hylke C Donker, et al.
Pageof 1